In advanced stages of cancer, when the disease is usually detected, CD4 and CD8 T cell responses are often ineffective and at best only slow down tumor progression due to low tumor immunogenicity, influence of the TME, or an interruption of the cancer immune cycle. This evidence concerns the gene CD4 and cancer.